Intraday Screener (Update Freq - 1 Min)   Price/Vol, Pivots, New High    SMA / EMA    Over Bought/Sold   Tech Indicators   Candlestick
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Fundamental Analysis of Mangalam Drugs Organics (MANGALAM)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

You can now fully customise Watchlist by chosing any combination of your favorites Technical And Fundamental paramenter.

CAGR Growth - Mangalam Drugs & Organics

CAGR Growth Period Book value Per Share % Operating cash Flow % Earning Per Share % Dividend % EBITDA % Net Income % Revenue % Revenue Per share % Operating Profit % Operating Profit Per Share% EBITDA Per share % Year Range
1 Year -8.955 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 18-19
3 Year 17.93 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 16-19
5 Year 27.98 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 14-19
7 Year 11.14 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12-19
10 Year 7.31 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 09-19

Balance Sheet of Mangalam Drugs & Organics

Year Book Value Per Share Capital Work In Progress Net Block Reserves EQ Capital Shareholdings Working Capital Shareholder's Funds Total Debt Current Liablities Total Liablities Cash & Bank Balances Total Assets Capital Employed Current Assets
31_Mar_19 60.49 0.200 101.26 79.93 15.83 53.17 95.76 59.11 54.26 113.37 1.43 209.13 154.87 107.43
31_Mar_18 66.44 0.070 101.91 89.35 15.83 70.47 105.18 68.93 63.50 132.43 0.430 237.61 174.11 133.97
Balance sheet for last 15 Years with 14 Indicators



Cash Flow of Mangalam Drugs & Organics

Year Cash EPS Cash From Financial Activity Cash From Investing Activity Cash From Operating Activity Net cash Flow
31_Mar_19 0.000 0.000 0.000 0.000 0.000
31_Mar_18 15.53 -8.820 -15.950 24.58 -0.200
Cash Flow for last 15 Years

Income Statement of Mangalam Drugs & Organics

Year Corporate Tax Rate Depreciation Expense Total Dividend EBITDA EPS (Earning Per Share) Income Tax Interest Net Income Outstanding Shares Operating Profit Other Income Profit Before Tax Revenue Operating Expense Dividend Total Income Profit Before Depreciation And Tax
31_Mar_19 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.58 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
31_Mar_18 0.322 6.57 0.790 47.70 12.56 9.46 11.78 19.89 1.58 46.87 0.830 29.35 279.38 232.51 0.000 280.21 35.92
Income Statement for last 15 Years with 17 Parameters

Quarterly Income Statement Mangalam Drugs & Organics

Quarter Corporate Tax Rate Depreciation Expense EBITDA EPS Income Tax Expense Interest Net Income OutStanding Shares Operating Profit Other Income Revenue Total Annual Dividend Total Income Operating Expense Profit Before Depreciation and Tax Face Value
31_Mar_19 0.000 1.66 0.000 -3.800 0.000 2.53 -6.010 1.58 0.260 0.210 48.09 0.000 48.30 47.83 -2.060 10.00
31_Dec_18 0.000 1.83 0.000 -2.790 0.000 2.30 -4.420 1.58 -0.990 0.050 48.58 0.000 48.63 49.57 -3.240 10.00
Quarterly Income Statement for last 26 Quarters with 16 Parameters



Risk , price and valuations of Mangalam Drugs & Organics

Year Market cap Dividend Yield Earning Yield Account Cost of Debit Cost of Equity (CAPM Model) Credit/Default Spread Levered Beta PEG (Price by earning To Growth) PBV (Price To Book Value) PE (Price To earning) PS (Price to Sales - Revenue) Weight to debt (WACC) Weight of equity (WACC) WACC (Weighted cost of Capital) PCFO (Price to cash Flow from Operations) Enterprise value
31_Mar_19 87.30 0.000 0.000 0.000 0.071 0.000 -0.480 0.000 0.910 0.000 0.000 0.404 0.596 0.000 0.000 144.98
31_Mar_18 256.68 0.000 0.080 0.171 0.083 0.032 -0.510 0.000 2.44 12.90 0.920 0.212 0.788 0.078 10.44 325.18
Risk Price & Valuation for last 15 Years with 16 Parameters

Profitability And Management Efficiency of Mangalam Drugs & Organics

Year CROCI (Cash Returns on Capital Invested) Days in Working Capital EBITDA Margin Net Margin Operating cash Flow to Revenue Operating Margin ROCE (Return on Capital Employed) ROE (Return on Equity) Current ratio ROA (return on Assets) ROIC (Return on Invested capital) Asset Turnover CFO To Sales CFO To Turnover(TO) WC to TO Fixed Asset (FA) to TO CFROA (CF to ROA)
31_Mar_19 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.98 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
31_Mar_18 0.274 90.81 0.171 0.071 0.088 0.168 0.236 0.189 2.11 0.084 0.110 1.18 0.090 649.72 3.96 2.74 0.103
Profitability & Management Efficiency for last 15 Years with 17 Parameters

Quarterly Profitability /Ratios of Mangalam Drugs & Organics

Quarter EBITDA Margin IBT Margin Net Margin Operating Margin) Market Capitalization Dividend Yield Levered Beta Dividend Payout Retention Ratio
31_Mar_19 0.000 -0.125 0.000 0.005 87.30 0.000 0.000 0.000 0.000
31_Dec_18 0.000 -0.091 0.000 -0.020 115.88 0.000 0.000 0.000 0.000
Profitability & Management Efficiency for last 26 Quarters with 9 Parameters


Solvency & Fundamentals of Mangalam Drugs & Organics

Year Capitalization Ratio Interest Coverage Long Term Debt to EBITDA Long Term Debt to Equity (Net Worth) Solvency Ratio Dividend Payout Retention Ratio Times Interest Earned Cash Ratio Accruals CFO to Debt Debt To Assets Debt To Capital Assets to Shareholder Equity Dividend Cover
31_Mar_19 0.380 0.000 0.000 0.620 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.280 0.380 2.18 0.000
31_Mar_18 0.400 3.49 1.45 0.660 0.380 0.040 0.960 0.290 0.010 -4.690 0.360 0.290 0.400 2.26 15.91
Solvency & Fundamentals for last 15 Years with 15 Parameters

Financial Data From D'Market


(All analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.